These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 23319301)
1. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009. Fischer B; Jones W; Rehm J Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):438-42. PubMed ID: 23319301 [TBL] [Abstract][Full Text] [Related]
2. Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011. Fischer B; Jones W; Urbanoski K; Skinner R; Rehm J Drug Alcohol Rev; 2014 Jan; 33(1):19-26. PubMed ID: 24261474 [TBL] [Abstract][Full Text] [Related]
3. Correlations between population-levels of prescription opioid dispensing and related deaths in Ontario (Canada), 2005-2016. Fischer B; Jones W; Varatharajan T; Malta M; Kurdyak P Prev Med; 2018 Nov; 116():112-118. PubMed ID: 30217407 [TBL] [Abstract][Full Text] [Related]
4. Geographic Variations in Prescription Opioid Dispensations and Deaths Among Women and Men in British Columbia, Canada. Gladstone EJ; Smolina K; Weymann D; Rutherford K; Morgan SG Med Care; 2015 Nov; 53(11):954-9. PubMed ID: 26465123 [TBL] [Abstract][Full Text] [Related]
6. Trends and sex differences in prescription opioid deaths in British Columbia, Canada. Gladstone EJ; Smolina K; Morgan SG Inj Prev; 2016 Aug; 22(4):288-90. PubMed ID: 26195562 [TBL] [Abstract][Full Text] [Related]
7. Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010. Fischer B; Jones W; Krahn M; Rehm J Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1269-77. PubMed ID: 21755568 [TBL] [Abstract][Full Text] [Related]
8. Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009. Shield KD; Jones W; Rehm J; Fischer B Pain Res Manag; 2013; 18(2):69-74. PubMed ID: 23662288 [TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
10. Trends and changes in prescription opioid analgesic dispensing in Canada 2005-2012: an update with a focus on recent interventions. Fischer B; Jones W; Rehm J BMC Health Serv Res; 2014 Feb; 14():90. PubMed ID: 24572005 [TBL] [Abstract][Full Text] [Related]
12. Harms of prescription opioid use in the United States. Imtiaz S; Shield KD; Fischer B; Rehm J Subst Abuse Treat Prev Policy; 2014 Oct; 9():43. PubMed ID: 25352167 [TBL] [Abstract][Full Text] [Related]
13. Drug-related overdose deaths in British Columbia and Ontario, 1992-2004. Fischer B; Popova S; Rehm J; Ivsins A Can J Public Health; 2006; 97(5):384-7. PubMed ID: 17120877 [TBL] [Abstract][Full Text] [Related]
14. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000. Pilote L; Beck CA; Karp I; Alter D; Austin P; Cox J; Humphries K; Jackevicius C; Richard H; Tu JV; Can J Cardiol; 2004 Jan; 20(1):61-7. PubMed ID: 14968144 [TBL] [Abstract][Full Text] [Related]
15. Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths. Gladstone E; Smolina K; Morgan SG; Fernandes KA; Martins D; Gomes T CMAJ; 2016 Mar; 188(4):E67-E72. PubMed ID: 26622006 [TBL] [Abstract][Full Text] [Related]
16. Opioid analgesics and rates of fatal drug poisoning in the United States. Paulozzi LJ; Ryan GW Am J Prev Med; 2006 Dec; 31(6):506-11. PubMed ID: 17169712 [TBL] [Abstract][Full Text] [Related]
17. The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada. Marshall DA; Willison DJ; Grootendorst P; LeLorier J; Maclure M; Kulin NA; Sheehy OE; Warren L; Sykora K; Rahme E Health Policy; 2007 Nov; 84(1):1-13. PubMed ID: 17570558 [TBL] [Abstract][Full Text] [Related]
18. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. Dhalla IA; Mamdani MM; Sivilotti ML; Kopp A; Qureshi O; Juurlink DN CMAJ; 2009 Dec; 181(12):891-6. PubMed ID: 19969578 [TBL] [Abstract][Full Text] [Related]
19. Determinants of trends in prescription opioid use in British Columbia, Canada, 2005-2013. Smolina K; Gladstone E; Morgan SG Pharmacoepidemiol Drug Saf; 2016 May; 25(5):553-9. PubMed ID: 26947145 [TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia? Nielsen S; Bruno R; Lintzeris N; Fischer J; Carruthers S; Stoové M Drug Alcohol Rev; 2011 May; 30(3):291-9. PubMed ID: 21545560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]